This positive cooperation between PPAR-γ and components of MAPK cascade in promoting tumor initiation and progression may explain the absence of therapeutic benefits of TZDs in some cancer patients and adds significant complexity to the PPAR-γ functions in cancer biology. The gene discussed is PPARG; the disease is cancer.